SEO URLwww.firestrike.ai/deals/day-one-biopharma-servier-acquisition-2026-13
acquisitionAnnounced · Mar 8, 2026medicalSource · SpeculativeArticle · Factual
Servier acquires Day One Biopharma
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
$2.5B
Target
Day One Biopharma
NASDAQ: DAWN · Brisbane, California
Acquirer
Servier
Full Acquisition
Status
Pending
Servier agreed to acquire Day One Biopharma. Reported deal value: $2.5B. Status: Pending. Sector: medical. Target headquarters context: Brisbane, California, United States.
This page summarizes publicly available information about the transaction as of 2026-03-08. Figures and status may change as filings and press coverage update.
Under the terms of the agreement, Servier will purchase Day One Biopharmaceuticals shares for $21.50 each in cash
Deal timeline
Announced
Mar 8, 2026 · techstory.in
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in medical with a reported deal value of $2.5B. Figures and status may change as sources update.
Sources: techstory.in · Primary article · FireStrike proprietary index